Assessment of gastrointestinal involvement

Clinical and Experimental Rheumatology

Volumn 21, Issue 3 SUPPL. 29, 2003, Pages

  Clements, Philip J ^a   Becvar, R ^b   Drosos, A A ^c   Ghattas, L ^d   Gabrielli, A ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^c UNIVERSITY OF IOANNINA   (Greece)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Esophagus; Gastrointestinal tract; Large intestine; Small intestine; Stomach

Indexed keywords

ANUS; COLON; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ESOPHAGUS; ESOPHAGUS MOTILITY; GASTROINTESTINAL DISEASE; HUMAN; MIGRATING MYOELECTRIC COMPLEX; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECTUM; REVIEW; SMALL INTESTINE; SMOOTH MUSCLE; STOMACH; SYSTEMIC SCLEROSIS; METHODOLOGY; REPRODUCIBILITY; RHEUMATOLOGY; STANDARD;

GASTROINTESTINAL DISEASES; HUMANS; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY; SCLERODERMA, SYSTEMIC;

EID: 0142058068     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. SJOGREN RW: Review: Gastrointestinal disorders in scleroderma. Arthritis Rheum 1994; 37: 1265-82.
2. COHEN S, RISHER R, LIPSHUTZ W, TURNER R, MYERS A, SCHUMACHER R: The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin Invest 1972; 51: 2663-8.
3. ZAMOST BJ, HIRSCHBERG J, IPPOLITI AF, FURST DE, CLEMENS PJ, WEINSTEIN WM: Esophagitis in scleroderma: Prevalence and risk factors. Gastroenterology 1987; 92: 421-8.
4. KLEIN HHA, WALD A, GRAHAM TO, CAMPBELL WL, STEEN VD: Comparative studies of esophageal function in systemic sclerosis. Gastroenterology 1992; 102: 1551-6.
5. MURPHY JR, MCNALLY P, PELLER P, SHAY SS: Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis. Dig Dis Sci 1992; 37: 833-41.
6. WEGENER M, ADAMEK RJ, WEDMANN J, JERGAS M, ALTMEYER P: Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 1994; 39: 2209-15.
7. MADSEN JL, HENDEL L: Gastrointestinal transit time of radio-labeled meal in progressive systemic sclerosis. Dig Dis Sci 1992; 37: 1404-8.
8. CLEMENTS PJ, LACHENBRUCH PA, STERZ M et al.: Cyclosporine in systemic sclerosis. Results of a forty-eight week open safety study in ten patients. Arthritis Rheum 1993; 36: 75-83.
9. GREYDANUS MP, CAMILLERI M: Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989; 96: 110-5.
10. METCALF AM, PHILLIPS SF, ZINSMEISTER AR, MACCARTY RL, BEART RW, WOLFF BG: Simplified assessment of segmentai colonic transit. Gastroenterology 1987; 92: 40-7.
11. COHEN S, LAUFER I, SNAPE WJ, SHIAU Y-F, LEVINE GM, JIMENEZ S: The gastrointestinal manifestations of scleroderma. Pathogenesis and management. Gastroenterology 1980; 769: 155-66.
12. EDENBRANDT L, THEANDER E, HOGSTROM M, SCHEJA A, AKESSON A, PALMER J: Esophageal scintigraphy of systemic sclerosis. J Nucl Med 1995; 36: 1533-8.